Ann: Company Announcement - The Seydel Companies, page-16

I agree partly with Marcellus and partly with you
There's a reasonable amount of cash on hand at the present
I would hope that income from Optiflox for the December 1/4 will be over $500K and payment for purchases lower (refer last 1/4 report).
The disappointing aspect from my point of view is the lack of any, and I mean ANY progress with the rollout of Optiflox in Australia - after all they did put on an extra sales guru last year and he has so far contributed zilch in sales and/or new customers whilst obviously contributing towards an increase in costs.
And the obvious visits to the USA would have increased December 1/4 expenses - hope they don't spend travel $ to the extent of our Federal and State Politicians do !!!
Anyway I'm still with this Company for the remainder of this calendar year - if the Tartana deal doesn't work out or if they are not substantially cash flow positive by 12/2018 then I'm OUT